HOME >> BIOLOGY >> NEWS
Early infection and rejection detection

TROY, N.Y. Julie Stenken, associate professor of analytical chemistry at Rensselaer Polytechnic Institute in Troy, N.Y., has received a four-year, $750,000 grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to develop a new technique that can be used to study the body's reaction to medical implants at the cellular level. Millions of medical devices, including catheters, pacemakers, vascular grafts, and glucose sensors, are regularly implanted into humans. Despite the frequency of these procedures, implantation still poses a risk of serious side effects, including implant site infection and rejection of the implanted device. The microdialysis technique can provide information that may someday allow doctors to spot infection earlier and prevent rejection from occurring.

Tiny Samples Provide New Understanding
A microdialysis probe (the size of a 0.5 mm pencil lead) is used to withdraw a tiny sample of extracellular fluid at the site where the implant and the body's tissues meet. Analysis of the sample can detect the presence and amount of a variety of chemical markers called cytokines that may indicate early signs of responses to an implant such as infection or rejection. "If you can understand the chemical communication that is going on at the implantation site, you can ultimately bioengineer the site to make it do what is appropriate for the device," says Stenken. "The tools to measure these chemical reactions are just starting to become available to us." Stenken is collaborating with Albany Medical Center co-investigators Daniel Loegering and Michelle Lennartz.

The NIBIB coordinates with the biomedical imaging and bioengineering programs of other agencies and the National Institutes of Health to support imaging and engineering research with potential medical applications.

Stenken's microdialysis project is part of Rensselaer's focal effort to advance biotechnology discoveries for the benefit
'"/>

Contact: Joely Johnson
johnsj2@rpi.edu
518-276-6098
Rensselaer Polytechnic Institute
24-Jul-2003


Page: 1 2

Related biology news :

1. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
2. Early detection hope for eye disease
3. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
4. Early dexamethasone exposure has long-term neurodevelopment, neuroendocrine effects
5. Early predictor of breast cancer aggressiveness
6. Early treatment confirmed as key to stroke recovery
7. Early identification of kidney disease cost-effective only when directed at high-risk patients
8. Early promise for treatment of Ebola
9. Early treatment can prevent severe vision loss in premature infants
10. Early hominids may have behaved more human than we had thought
11. Early-life environments shape development of stress behaviors and learning abilities in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/4/2019)... NEW YORK (PRWEB) , ... October 03, 2019 , ... ... the genome that cells hand down from one generation to the next. In a ... mutations can modulate the activity of this enzyme, leading to cancers and other diseases. ...
(Date:9/30/2019)... , ... September 30, 2019 , ... ... focused on increasing the capacity of life science organizations to accelerate innovation and ... Francisco, CA on October 4th. , What: Just 30 days to 21 CFR ...
(Date:9/25/2019)... ... September 25, 2019 , ... ... it ranked No. 3094 on Inc. Magazine’s annual Inc. 5000 list, the most ... growth of 120 percent. Based on this growth, the Houston-based firm also ranked ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... KITCHENER, Ontario (PRWEB) , ... October 02, 2019 ... ... protein sequencing using mass spectrometry, is pleased to announce that it has moved ... mass spectrometers among other analytical instruments, the new facility demonstrates the company's continuous ...
(Date:9/24/2019)... and WALTHAM, Mass. (PRWEB) , ... ... ... the leading global provider of advanced delivery technologies, development, and manufacturing solutions ... Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of ...
(Date:9/17/2019)... ... September 17, 2019 , ... Catalent, ... Project and Clinical Supplies Management, Asia Pacific (APAC) will present at the upcoming ... on Sept. 25-26, 2019. , On Thursday, Sept. 26, at 10:10 a.m., Ms. ...
(Date:9/17/2019)... ... September 16, 2019 , ... ... CNBC on Saturday, September 21st @11:00am ET. Check local listings for more information ... (Credo Biomedical), a molecular diagnostic company from Singapore dedicated to developing advanced ...
Breaking Biology Technology:
Cached News: